EBERBACH, Germany—Fortigel®’s ability to stimulate the regeneration of cartilage was confirmed by the results of two independent investigations presented at the congress of the Osteoarthritis Research Society International (OARSI) in Montreal. A clinical trial performed by Harvard Medical School and Tufts Medical Center demonstrated the efficacy of Fortigel on the basis of magnetic resonance images (MRI). Working in collaboration with Kiel University, scientists at the Kiel-based Collagen Research Institute (CRI) then gathered experimental evidence of the effects of Fortigel on cartilage cells.
The administration of Fortigel can prevent joint degeneration and counteract load-induced wear of the articular cartilage. “Unlike other substances which focus on short-term pain relief, Fortigel tackles the root causes of osteoarthritis and cartilage degeneration,” explained Dr. Klaus Flechsenhar, Director of Medical Research at GELITA AG. Previous clinical trials had already shown that the substance promotes mobility and reduces pain.